Prospective study evaluating the effect of intravitreal injection of bevacizumab on intraocular pressure in patients with macular oedema or choroidal neovascularization

Trial Profile

Prospective study evaluating the effect of intravitreal injection of bevacizumab on intraocular pressure in patients with macular oedema or choroidal neovascularization

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Feb 2016

At a glance

  • Drugs Bevacizumab (Primary)
  • Indications Choroidal neovascularisation; Retinal oedema
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top